Intrapleural Fibrinolysis and DNase versus VATS for the treatment of pleural empyema: a randomized, controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513596-40-00

Enrollment

184

Registered

2024-06-26

Start date

2024-06-28

Completion date

Unknown

Last updated

2024-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural empyema

Brief summary

see protocol

Detailed description

see protocol, see protocol

Interventions

DRUGDORNASE ALFA

DRUGALTEPLASE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
see protocol	—

Secondary

Measure	Time frame
see protocol, see protocol	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026